April 23, 2009

Schumer, Gillibrand Announce $237,000 to Improve Medical Research in the Hudson Valley

Funds Will Support Research, Treatment for Schizophrenia

Washington, D.C. - U.S. Senators Charles Schumer and Kirsten Gillibrand today announced $237,000 to upgrade and improve resources at the Nathan S. Kline Institute for Psychological Research. The funds will help move forward on critical research and treatment to help improve the lives of all New Yorkers, and are part of the American Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped pass earlier this year.

"Investing in these institutions makes sense in both the short run and the long run," said Schumer.  "Immediately it will create jobs and advance the Hudson Valley's position at the cutting edge of the medical research, while in the long run it will allow our parents, grandparents, sons, and daughters to live longer, healthier lives."

"It is critical that we invest in the life-saving research at our world class facilities in the Hudson Valley," said Senator Gillibrand. "Federal funding for this cutting edge research will help with medical diagnosis and treatment while promoting economic growth in the Hudson Valley. During these tough economic times, I will continue to work with Senator Schumer to ensure that New York receives its fair share of federal dollars."

The Nathan S. Kline Institute for Psychological Research will receive $237,000 for research and treatment into schizophrenia.

Senators Schumer and Gillibrand are strong supporters of President Obama's economic plan. The investment will help create or save more than 200,000 jobs in New York, while laying the foundation of future economic growth with critical investments in health care technology, education, infrastructure and renewable energy.